Heparin Cofactor II Modulates the Response to Vascular Injury
- 1 March 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 27 (3) , 454-460
Abstract
Heparin cofactor II (HCII) has several biochemical properties that distinguish it from other serpins: (1) it specifically inhibits thrombin; (2) the mechanism of inhibition involves binding of an acidic domain in HCII to thrombin exosite I; and (3) the rate of inhibition increases dramatically in the presence of dermatan sulfate molecules having specific structures. Human studies suggest that high plasma HCII levels are protective against in-stent restenosis and atherosclerosis. Studies with HCII knockout mice directly support the hypothesis that HCII interacts with dermatan sulfate in the arterial wall after endothelial injury and thereby exerts an antithrombotic effect. In addition, HCII deficiency appears to promote neointima formation and atherogenesis in mice. These results suggest that HCII plays a unique and important role in vascular homeostasis.Keywords
This publication has 63 references indexed in Scilit:
- N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfateGlycobiology, 2006
- Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor IIBlood, 2006
- High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stentingThrombosis and Haemostasis, 2004
- A Model of Primary Atherosclerosis and Post-Angioplasty Restenosis in MiceThe American Journal of Pathology, 2003
- Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-β in carotid artery of atherosclerotic rabbitsAtherosclerosis, 2003
- Inflammation in atherosclerosisNature, 2002
- Altered Dermatan Sulfate Structure and Reduced Heparin Cofactor II-stimulating Activity of Biglycan and Decorin from Human Atherosclerotic PlaqueJournal of Biological Chemistry, 2000
- Heparin cofactor IIBlood Coagulation & Fibrinolysis, 1998
- Activation of heparin cofactor II by heparin oligosaccharidesBiochemical and Biophysical Research Communications, 1988
- Effects of fibroblasts and endothelial cells on inactivation of target proteases by protease nexin‐1, heparin cofactor II, and C1‐inhibitorJournal of Cellular Biochemistry, 1988